← SynDRA
AZD-5991
SynDRA canonical compound SYN0039628 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MCL1 |
|---|
| Mechanism of action | MCL1 inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MCL1 ANTAGONIST
- MCL1 INHIBITOR
Cross-references
Synonyms
- AZD5991
- KBQCEQAXHPIRTF-UHFFFAOYSA-N
- AZD-5991 (Racemate)
- UNII-E3T5XXY9HX
- E3T5XXY9HX
- SCHEMBL19472011
- EX-A2673
- HY-101533A
- CS-0077938
- E4W
- RefChem:560463
- AZD 5991
- AZD-5991 Racemate
- AZD-5991 S-enantiomer
- AZD5991S
- C35H34ClN5O3S2
- orb1710350
- orb2946029
- SCHEMBL29380383
- EX-A2673A
- EX-A2673B
- GTPL11783
- AZD 5991 [WHO-DD]
- US10196404, Example 1
- US10196404, Example 2
- US10196404, Example 3
- BDBM333146
- GLXC-20222
- TKD01083
- TKD06182
- AZD-5991?
- NSC807055
- s8643
- AKOS040732511
- NSC-807055
- T10434L
- AZD 5991 (AZD5991)
- NCGC00689122-01
- BA166834
Look up AZD-5991 in the interactive SynDRA portal →